copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
TREMFYA® - cloud. e. janssen. com TREMFYA® is a prescription medicine used to treat adults and children 6 years and older who also weigh at least 88 pounds (40 kg) with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light) TREMFYA® is a prescription medicine used to treat adults and children 6 years and older who also
Rep-Provided SPRAVATO® Resource Rep-Provided SPRAVATO® Resources Janssen has several SPRAVATO® resources that may be helpful to you when communicating with patients or your referral community You may request the following supplementary resources from your SPRAVATO® representative:
Digital and Traditional Media Communications FAQ - Janssen The information in this toolkit is meant to be educational to help inform your communications Your use of these materials is not an endorsement by Johnson Johnson of your treatment center In no event is Johnson Johnson responsible for your use of this material Modifications are prohibited and Johnson Johnson has no liability for any modifications made Your use of this material does
OPSYNVI® (macitentan et tadalafil) devient le premier et le seul . . . OPSYNVI® (macitentan et tadalafil) devient le premier et le seul traitement d’association à doses fixes uniquotidien approuvé par Santé Canada pour les patients atteints d’hypertension artérielle pulmonaire (HTAP)
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other . . . The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of ustekinumab and new users of other biologic therapies among adult participants with Crohn's disease (CD) or ulcerative colitis (UC)
Oncologia e Hematologia│ Janssen Portugal O cancro afeta milhões de pessoas As nossas soluções inovadoras na Oncologia visam dar qualidade de vida aos doentes e descobrir as curas do amanhã
Tremfya - cloud. e. janssen. com We look forward to sharing more with you about TREMFYA ® (guselkumab) In the meantime, if you have any questions, feel free to call a Janssen CarePath Care Coordinator at 877‑CarePath (877‑227‑3728), Monday‑Friday, 8:00 AM to 8:00 PM ET Multilingual phone support is available
Inmunología | Janssen Bolivia Janssen posee vasta trayectoria de innovación en la terapéutica con anticuerpos monoclonales Nuestros productos en esta área se constituyen en recursos terapéuticos de demostrada eficacia en una variedad de enfermedades mediadas por la inmunidad, tales como artritis reumatoidea, enfermedad inflamatoria intestinal (enfermedad de Crohn, colitis ulcerosa), espondilitis anquilosante, artritis